4D Molecular Therapeutics, Inc. FDMT
12.46 USD +0.21 (+1.71%)
Nov 9, 2026, 3:58 PM EST
12.15 Day range 12.71
7.19 52-week range 16.76
- YTD
- +66.13%
- 1 year
- +18.67%
FDMT revenue history
Revenue is income from the company’s ordinary business activities.
85,209,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 85,209,000 | 85,172,000 | 230194.59% |
| FY 2024 | 2024-12-31 | 37,000 | -20,686,000 | -99.82% |
| FY 2023 | 2023-12-31 | 20,723,000 | 17,594,000 | 562.29% |
| FY 2022 | 2022-12-31 | 3,129,000 | -14,909,000 | -82.65% |
| FY 2021 | 2021-12-31 | 18,038,000 | 4,426,000 | 32.52% |
| FY 2020 | 2020-12-31 | 13,612,000 | 6,626,000 | 94.85% |
| FY 2019 | 2019-12-31 | 6,986,000 | -7,144,000 | -50.56% |
| FY 2018 | 2018-12-31 | 14,130,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:43.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.